Novavax's total assets for Q2 2026 were $955.58M, a decrease of -8.40% from the previous quarter. MX:NVAX total liabilities were $1.15B for the fiscal quarter, a -3.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.